Michael Berger

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology Memorial Sloan Kettering Cancer Center

Seminars

Tuesday 6th October 2026
The Power of Modular CGP: Enabling Precision Oncology Across Drug Development
5:40 pm
  • Explore the origins of MSK-IMPACT® and its real-world impact on patient care
  • Gain insights into the assay’s robust analytical performance at scale, enabling decentralized sites across the world to generate concordant and high-quality data
  • Understand how a flexible, future-proof CGP infrastructure helps pharma keep pace with an evolving biomarker landscape, and how SOPHiA GENETICS is already delivering this across the drug development continuum through hands-on partnerships with key diagnostic players
Michael Berger